FMT for dementia and cognitive decline: what the evidence shows
Watching a parent’s memory fade is hard, and it’s natural to look for anything that might help. Dementia isn’t one disease: Alzheimer’s, vascular and mixed dementia all affect memory and thinking, and researchers now link each of them to changes in the gut. Here is what studies of fecal microbiota transplant (FMT) in dementia actually found, where they fall short, and when FMT is or isn’t appropriate. This page comes from Resplice Institute, with centres in Hyderabad and Mumbai.
Evidence level 2 of 5
Case reports and small studies. See the studies
Can FMT improve memory in dementia?
Early human data suggest it might, in some patients. In a 2022 Korean study, people with dementia who received FMT for C. difficile infection had better memory scores afterwards than similar patients treated with antibiotics alone. Animal studies point the same way. But the numbers are small and randomised trials are still needed, so FMT for dementia remains investigational.
Key points
- No treatment, including FMT, has been shown to reverse dementia.
- In the Korean study, median MMSE after treatment was 16 with FMT against 10 with antibiotics alone.
- Every patient in that study also had a serious bowel infection, and the groups were not randomised.
- With age, the gut microbiome tends to lose variety, which researchers link to inflammation that may reach the brain.
- Outside recognised indications, FMT for dementia belongs in ethics-approved research.
What is fecal microbiota transplant (FMT)?
Fecal microbiota transplant (FMT), also called faecal microbiota transplantation or a stool transplant, moves a complete community of gut bacteria from a carefully screened, healthy donor into a patient’s bowel. The aim is to rebuild a balanced gut microbiome. It is usually given by colonoscopy or enema; some research studies use capsules.
FMT is an established treatment for recurrent C. difficile infection, where gastroenterology guidelines recommend it for suitable adults.2 For dementia it is still being researched, and it is not an approved treatment.
FMT for dementia at a glance
| Status | Investigational. Not an approved treatment for dementia. |
|---|---|
| Strongest human evidence | A 20-patient comparison in Korea and small case series.1 |
| What changed | Median MMSE was 16 after FMT against 10 after antibiotics alone. |
| Biggest uncertainty | Not randomised; every patient had C. difficile infection; dementia types were mixed. |
| Standard care | Diagnosis of the dementia type, prescribed medicines, managing blood pressure and diabetes, and caregiver support. |
| Where FMT fits | Within ethics-approved research, or for a recognised indication such as recurrent C. difficile infection. |
Why does gut health matter for an ageing brain?
As we age, the gut microbiome often becomes less diverse and the gut lining can become more permeable. Researchers think this may raise the low-grade inflammation that reaches the brain and speeds up cognitive decline.
FMT transfers a whole, balanced microbial community from a screened donor, with the aim of restoring diversity that probiotics alone usually cannot.
For Alzheimer’s disease specifically, see FMT for Alzheimer’s disease, which covers the case reports in more detail.
- Two-way effectIn mice, FMT from healthy donors improved spatial memory and lowered brain inflammation, while microbiota from donors with colitis made memory and amyloid build-up worse.3
- Leaky gutIn Alzheimer’s mice, an unhealthy microbiome came with a weaker gut barrier and inflammation throughout the body.4
- Everyday influencesDiet, sleep, activity, antibiotics and other medicines all shape the microbiome, which is why nutrition and lifestyle support matter alongside any treatment.
How common is dementia in India?
The LASI-DAD study estimates that 7.4% of Indians aged 60 and over, about 8.8 million people, live with dementia, with higher rates in women and in rural areas.5 People aged 60 and over are projected to make up nearly 20% of India’s population by 2050, so the number of families affected will keep growing.
- Nearly 20 in 100Indians projected to be aged 60+ by 2050
What does the research say about FMT for dementia?
Here is every key study, placed on our five-step evidence ladder. Click any citation to read the original paper.
- 5Guideline-recommended careRecurrent C. difficile
- 4Multiple randomised trials and meta-analyses
- 3Small randomised trials
- 2Case reports and small studiesDementia evidence is here
- 1Laboratory and animal research
Level 5 shows where fully proven FMT sits today, for comparison.
Guideline-recommended care
FMT is a guideline-recommended treatment for recurrent C. difficile infection
The American Gastroenterological Association’s 2024 guideline recommends fecal microbiota-based therapy to prevent recurrent C. difficile infection in suitable adults. It is shown here as the reference point: this is what fully proven FMT looks like.2
Multiple randomised trials and meta-analyses
No meta-analyses of randomised trials yet.
Small randomised trials
Only one small randomised trial (20 patients) has been reported so far; larger trials are needed.6
Case reports and small studies
Ten people with dementia had better memory scores after FMT than ten treated with antibiotics
Patients with dementia and severe C. difficile infection who received FMT had a median MMSE of 16 afterwards, against 10 in the antibiotic group.1
Five patients with Alzheimer’s dementia improved on standard memory tests
Median MMSE rose from 13 to 18 and CDR-SB fell from 10.0 to 5.5 after FMT.7
A 2025 review found five human studies with 26 patients in total
FMT was associated with better cognition, but the reviewers judged the clinical evidence limited and too varied to pool.6
Laboratory and animal research
FMT from healthy donors improved memory in Alzheimer’s mice
Mice showed better spatial memory, less amyloid and lower inflammatory signals in gut and brain; microbiota from colitis donors did the opposite.3
What the researchers concluded
“FMT may effectively delay cognitive decline in patients with dementia”
“…clinical evidence remains limited”
Our reading of the evidence
The strongest human data so far come from the 2022 Korean comparison, but it was not randomised and every patient also had a serious bowel infection, so part of the benefit may come from clearing that infection. Most research also groups different types of dementia together. Outside recognised indications, FMT for dementia should be used only within an ethics-committee-approved research study, with memory scores measured before and after.
Published case reports: FMT for dementia
These studies were carried out by independent research teams and published in peer-reviewed journals. The patients are not Resplice patients, and results vary from person to person.
Twenty people with dementia and severe C. difficile infection, compared side by side
Published case: Park SH, Aging (Albany NY), 2022
- Patients
- Twenty adults aged 62 to 91 (80% women) with dementia and severe C. difficile infection. Ten received FMT and ten were treated with antibiotics only.
- Treatment
- FMT from healthy donors, with memory tests and stool microbiome analysis before treatment and about three weeks afterwards.
- What changed
- After treatment the FMT group had higher MMSE scores (median 16 against 10) and lower CDR-SB scores (5.5 against 8.0, where lower is better). Their gut microbiome also shifted.
- What it can’t tell us
- Patients were not randomised, numbers were small, and the infection itself can worsen confusion.
Five patients with Alzheimer’s dementia followed for three months
Published case: Kim JS, Ther Adv Neurol Disord, 2024
- Patients
- Five people with Alzheimer’s dementia.
- Treatment
- FMT, with cognitive testing plus stool and gene-expression analysis before and after.
- What changed
- Median MMSE rose from 13 to 18 and CDR-SB fell from 10.0 to 5.5. Researchers also saw more Bacteroidaceae, fewer Enterococcaceae and changes in genes linked to fat metabolism.
- What it can’t tell us
- A very small, preliminary study with no comparison group.
Who might FMT be suitable for?
May be appropriate if
- You have recurrent C. difficile infection, a recognised indication for FMT, alongside dementia or memory decline
- You are taking part in an ethics-committee-approved research study of FMT in dementia
- The type of dementia has been assessed by a neurologist, and risks and benefits have been discussed with you and your family
- A caregiver can attend appointments and help track changes at home
Not advised if
- Confusion has come on suddenly (delirium): this needs urgent medical care first
- Your immune system is severely weakened
- Advanced frailty would make the procedure unsafe
- You see FMT as a replacement for prescribed treatment
What happens at an FMT assessment at Resplice?
Nobody is booked straight in for FMT. A typical pathway has five steps, and you can stop at any point. Your existing doctors are kept informed throughout.
Initial assessment
We review the type and stage of dementia, current medicines, other health conditions and gut symptoms with the patient and family.
Gut health evaluation
Blood and stool tests look for infections, inflammation or other problems that need treating first, and help decide whether FMT is appropriate at all.
Microbiome testing and treatment planning
We test the gut microbiome and record baseline scores on standard memory and daily-function tests, then agree a written plan for route, sessions and review points.
FMT procedure
If FMT is appropriate, screened donor microbiota is given by colonoscopy, retention enema or another route chosen for the patient’s comfort and safety.
Follow-up and long-term monitoring
Memory testing, daily-function checks and microbiome results are repeated at agreed intervals and shared with the treating neurologist.
Is FMT safe? Side effects and donor screening
Healthy donor
A healthy adult volunteer offers to donate.
Screening
Health questionnaire plus blood and stool tests.
Stool bank
Approved samples are processed and stored.
Preparation
Prepared under laboratory conditions.
Delivery
Given by colonoscopy, enema or another route.
Engraftment
Donor microbes settle and grow in the gut.
FMT is generally well tolerated when donors are carefully screened. The most common effects are short-lived bloating, cramps, loose stools or a mild fever. Rare but serious infections have been reported worldwide when donor screening was inadequate, which is why screening matters more than any other step.
People with severely weakened immune systems face higher risks, so your own health is reviewed in detail before FMT is considered, and the benefits, risks and alternatives are explained before you give written consent.
International donor-screening standards include
- A detailed health, travel and lifestyle questionnaire for every donor
- Blood tests for infections such as HIV, hepatitis and syphilis
- Stool tests for C. difficile, disease-causing bacteria, parasites and drug-resistant organisms
- Repeat testing over time, so that every batch can be traced from donor to patient
Resplice Institute’s FMT service in Hyderabad and Mumbai
Services
Clinical gut-health assessment, microbiome testing, FMT for recognised indications, post-treatment monitoring, and nutrition and lifestyle guidance.
Donor material
Supplied from Resplice Institute’s stool bank. Our donor-screening protocol is available on request.
Locations
Hyderabad (Manikonda and Patancheru, Telangana) and Mumbai, Maharashtra.
Charges
Fees depend on the tests and treatment plan, and are given to you in writing before any treatment.
Questions to ask before you consider FMT
Whether you come to us or go elsewhere, these are fair questions to put to any FMT provider. A good clinic will welcome them.
- Why do you think FMT is appropriate for me, and what is the evidence for my condition?
- Is this a recognised indication for FMT, or part of an ethics-committee-approved study?
- How are donors screened, and can I see your screening protocol?
- Which route will you use, how many sessions will I need, and how do I prepare?
- Which side effects should I watch for, and who do I call if I feel unwell afterwards?
- How will we measure whether it has helped, and when?
- Should any of my current medicines change? (Never stop a medicine on your own.)
- What is the total cost, including tests and follow-up visits?
Frequently asked questions about FMT for dementia
Can FMT reverse dementia?
No treatment currently reverses dementia. Studies suggest FMT may improve some patients’ memory scores in the short term, but it has not been shown to stop or reverse the disease in controlled trials.
Does FMT help vascular dementia as well as Alzheimer’s?
Most FMT research so far has focused on Alzheimer’s disease or on mixed groups of people with dementia, so there is not enough data to say whether vascular or other types respond differently. We discuss this openly at assessment.
What is the link between gut bacteria and memory?
Gut microbes affect inflammation, the gut barrier and the chemical signals that travel to the brain through the bloodstream and the vagus nerve. Animal studies show that changing the microbiome can change memory and brain inflammation.
How do you measure whether FMT is working?
We record baseline scores on standard memory tests such as MMSE or MoCA, daily-function measures and gut symptoms, then repeat them at agreed points after treatment.
Will FMT interact with dementia medicines?
FMT is not known to interact with common dementia medicines, and they should be continued. Antibiotics can reduce the effect of FMT, so tell us about any recent or planned courses.
Is FMT safe for older adults with dementia?
Studies have included patients up to their early 90s. Older adults often have other conditions and medicines, so we screen both patient and donor carefully and choose the gentlest suitable route.
Who are stool donors and how are they screened?
Donors are healthy adult volunteers. Under international screening standards, each donor completes a detailed health questionnaire and passes blood and stool tests for infections and drug-resistant bacteria, with testing repeated over time. You are entitled to ask any FMT provider, including us, to explain their donor-screening protocol before treatment.
Where are Resplice Institute’s FMT centres?
Resplice Institute’s gut microbiome and FMT service is available in two cities: Hyderabad, at our Manikonda and Patancheru centres in Telangana, and Mumbai, Maharashtra. Assessments, microbiome testing and follow-up can be arranged in either city.
How much does FMT cost in Hyderabad and Mumbai?
Cost depends on the tests you need, the delivery route and the number of sessions in your plan. We give you a written estimate after the first consultation, before any treatment begins.
Contact and appointments
For an appointment, please bring recent memory test results, scans and a list of current medicines.
Our FMT centres
Hyderabad: Manikonda
Vaishnavione, 3rd Floor, above Vijetha Supermarket, Shivapuri Colony, Manikonda, Hyderabad, Telangana 500089Hyderabad: Patancheru
RM/6 5-98, beside Rainbow Meadows, Krishna Reddy Pet, Patelguda, Patancheru, Telangana 502319Mumbai
[Full clinic address and PIN code]Mumbai, Maharashtra
References
- Park SH, et al. Fecal microbiota transplantation can improve cognition in patients with cognitive decline and Clostridioides difficile infection. Aging (Albany NY). 2022;14(16):6449–6466. doi.org/10.18632/aging.204230
- Peery AF, et al. AGA clinical practice guideline on fecal microbiota-based therapies for select gastrointestinal diseases. Gastroenterology. 2024;166(3):409–434. doi.org/10.1053/j.gastro.2024.01.008
- Zhou C, et al. Bidirectional modulation of Alzheimer’s disease via gut microbiota: rescue by fecal transplantation from healthy donors and aggravation by colitis-associated dysbiosis. Front Neurosci. 2025. doi.org/10.3389/fnins.2025.1593854
- Kim MS, et al. Transfer of a healthy microbiota reduces amyloid and tau pathology in an Alzheimer’s disease animal model. Gut. 2020;69(2):283–294. doi.org/10.1136/gutjnl-2018-317431
- Lee J, et al. Prevalence of dementia in India: national and state estimates from a nationwide study (LASI-DAD). Alzheimers Dement. 2023;19(7):2898–2912. pubmed.ncbi.nlm.nih.gov/36637034/
- Felippe MFP, et al. Fecal matter transplantation and cognition: a systematic review in Alzheimer’s disease and related disorders. Alzheimers Dement. 2025;21(Suppl 5):e107684. doi.org/10.1002/alz70859_107684
- Kim JS, et al. Effect of altered gene expression in lipid metabolism on cognitive improvement in patients with Alzheimer’s dementia following fecal microbiota transplantation: a preliminary study. Ther Adv Neurol Disord. 2024;17. doi.org/10.1177/17562864231218181